Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
Biohaven pain spray aces test as C-suite shake-up sees incoming CFO, chief in chairman role
Fierce Biotech
Mon, 12/6/21 - 10:50 am
Biohaven
zavegepant
migraines
Tonix Cleared to Propel Migraine Therapy into Phase II
BioSpace
Tue, 11/23/21 - 08:52 pm
Tonix Pharmaceuticals
clinical trials
TNX-1900
migraines
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?
Fierce Pharma
Mon, 11/22/21 - 10:21 am
migraines
pharma marketing
JNJ
Topamax
Amgen
Biohaven
Eli Lilly
Teva Pharmaceutical
Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec
Fierce Pharma
Thu, 11/18/21 - 11:03 pm
Eli Lilly
Biohaven
migraines
clinical trials
Nurtec ODT
Emgality
Amid crowded migraine market, Lundbeck goes its own way
Pharmaforum
Mon, 11/15/21 - 10:42 am
Lundbeck
migraines
Lu AG09222
Citing migraine drug growth and pandemic, Lundbeck to cut 300 jobs and close India facility
Endpoints
Fri, 11/12/21 - 10:39 am
Lundbeck
R&D
layoffs
Vyepti
migraines
India
Biohaven, Pfizer enter up to $1.24 bln deal to market migraine drugs
Yahoo/Reuters
Tue, 11/9/21 - 10:38 am
Pfizer
Biohaven
migraines
rimegepant
zavegepant
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Biohaven
migraines
Nurtec ODT
Amgen
AbbVie
Biohaven migraine drug sales again top Wall Street forecasts
BioPharma Dive
Wed, 10/6/21 - 11:20 pm
Biohaven
migraines
Nurtec ODT
AbbVie’s Qulipta Set to Become Blockbuster in the Migraine Market
Clinical Trials Arena
Sun, 10/3/21 - 08:11 pm
AbbVie
Qulipta
migraines
FDA
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
Endpoints
Wed, 09/29/21 - 11:04 am
AbbVie
Qulipta
migraines
Allergan
Biohaven
FDA
No joy for Ajovy: Teva's migraine drug can't find a win in meta-analysis versus Biohaven, AbbVie meds
Fierce Pharma
Thu, 09/9/21 - 11:11 am
Teva Pharmaceutical
Eli Lilly
Amgen
Ajovy
Biohaven
migraines
Biohaven points up Nurtec dual-migraine approval with growing stable of celebrity users
Fierce Pharma
Tue, 08/24/21 - 10:47 am
Biohaven Pharmaceuticals
migraines
celebrity endorsements
Nurtec
digital advertising
DTC advertising
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug
BioSpace
Mon, 08/16/21 - 10:15 pm
Teva Pharmaceutical
patents
migraines
Ajovy
Eli Lilly
Emgality
Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma
BioPharma Dive
Wed, 07/14/21 - 10:34 pm
Biohaven
migraines
drug launches
DTC advertising
Nurtec
Why Glaxo should buy Biohaven
EP Vantage
Fri, 07/9/21 - 09:46 am
Biohaven
GSK
Nurtec
migraines
M&A
Biohaven Leaps After Posting $93M Sales for Migraine Drug
TheStreet.com
Wed, 07/7/21 - 12:00 pm
Biohaven
migraines
Nurtec
Slashing 186 jobs, Novartis hands off U.S. sales, marketing duties for migraine med Aimovig to Amgen
Fierce Pharma
Tue, 06/15/21 - 11:41 pm
Novartis
Amegen
Aimovig
migraines
Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study
Fierce Pharma
Tue, 06/15/21 - 10:35 am
Eli Lilly
Emgality
migraines
Biohaven
Nurtec
Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity
BioSpace
Fri, 06/4/21 - 10:37 am
AbbVie
migraines
atogepant
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »